BackLumos Pharma Overview

Lumos Pharma Net Income

Profitability analysis for LUMO.

Quarterly Net Income

-$7.47M
10.04% YoY

As of Sep 2024

Annual Net Income (TTM)

-$34.92M
10.63% YoY

Trailing 12 months ending Sep 2024

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...